Amid a months-long wait for clarity on the future of vaping in the United States, people on all sides of the tobacco harm reduction debate are growing anxious.
On January 14, a collection of public health nonprofits and tobacco control groups—including the Campaign for Tobacco-Free Kids (CTFK), the American Heart Association and Truth Initiative—sent a letter to Mitch Zeller, the director of the Food and Drug Administration’s Center for Tobacco Products (CTP).
The groups—many of which are funded by billionaire Michael Bloomberg and all of which want to clamp down on vaping—urged the agency to “expedite” its decisions on products that remain on the market without authorization. It had been more than four months, they noted with palpable agitation, since CTP had blown past court-ordered deadline to review vapor companies’ premarket tobacco product applications (PMTAs)—submissions, the FDA has stressed, that would be considered on a case-by-case basis.
Alex Norcia – Filter – 2022-01-21.
Want More Investigative Content?
